alexa Theoretical Study: Non-small Cell Lung Cancer Drugs
ISSN: 2150-3494

Chemical Sciences Journal
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th European Chemistry Congress
May 11-13, 2017 Barcelona, Spain

Ulku Dilek Uysal and Halil Berber
Anadolu University, Turkey
Posters & Accepted Abstracts: Chem Sci J
DOI: 10.4172/2150-3494-C1-009
Afatinib, crizotinib and ceritinib (Figure 1) have been used as a treatment for non-small lung cancer in recent years [1]. To the best of our knowledge; there has been no theoretical research about these three non-small cell lung cancer drugs in the literature. The theoretical investigation of these molecules is an urgent need to understand the residance mechanism of these drug active components.

Ulku Dilek Uysal has completed her PhD in 2001 from Gazi University and postdoctoral studies from Intitute of Chemical Technologies of Italian National Council of Research (CNR). She is proffessor of Anadolu University at Chemistry Department. She has published more than 25 papers.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version